Cargando…
Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833743/ https://www.ncbi.nlm.nih.gov/pubmed/33307274 http://dx.doi.org/10.1016/j.jgar.2020.11.022 |
| _version_ | 1783642132874002432 |
|---|---|
| author | Enoki, Yuki Igarashi, Yuki Watabe, Yuki Honma, Kyoka Suzuki, Yuto Hayashi, Yukitaka Hiraoka, Kana Taguchi, Kazuaki Matsumoto, Kazuaki |
| author_facet | Enoki, Yuki Igarashi, Yuki Watabe, Yuki Honma, Kyoka Suzuki, Yuto Hayashi, Yukitaka Hiraoka, Kana Taguchi, Kazuaki Matsumoto, Kazuaki |
| author_sort | Enoki, Yuki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7833743 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78337432021-01-26 Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials Enoki, Yuki Igarashi, Yuki Watabe, Yuki Honma, Kyoka Suzuki, Yuto Hayashi, Yukitaka Hiraoka, Kana Taguchi, Kazuaki Matsumoto, Kazuaki J Glob Antimicrob Resist Short Communication The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2021-03 2020-12-08 /pmc/articles/PMC7833743/ /pubmed/33307274 http://dx.doi.org/10.1016/j.jgar.2020.11.022 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Short Communication Enoki, Yuki Igarashi, Yuki Watabe, Yuki Honma, Kyoka Suzuki, Yuto Hayashi, Yukitaka Hiraoka, Kana Taguchi, Kazuaki Matsumoto, Kazuaki Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials |
| title | Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials |
| title_full | Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials |
| title_fullStr | Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials |
| title_full_unstemmed | Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials |
| title_short | Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials |
| title_sort | remdesivir for the treatment of coronavirus covid-19: a meta-analysis of randomised controlled trials |
| topic | Short Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833743/ https://www.ncbi.nlm.nih.gov/pubmed/33307274 http://dx.doi.org/10.1016/j.jgar.2020.11.022 |
| work_keys_str_mv | AT enokiyuki remdesivirforthetreatmentofcoronaviruscovid19ametaanalysisofrandomisedcontrolledtrials AT igarashiyuki remdesivirforthetreatmentofcoronaviruscovid19ametaanalysisofrandomisedcontrolledtrials AT watabeyuki remdesivirforthetreatmentofcoronaviruscovid19ametaanalysisofrandomisedcontrolledtrials AT honmakyoka remdesivirforthetreatmentofcoronaviruscovid19ametaanalysisofrandomisedcontrolledtrials AT suzukiyuto remdesivirforthetreatmentofcoronaviruscovid19ametaanalysisofrandomisedcontrolledtrials AT hayashiyukitaka remdesivirforthetreatmentofcoronaviruscovid19ametaanalysisofrandomisedcontrolledtrials AT hiraokakana remdesivirforthetreatmentofcoronaviruscovid19ametaanalysisofrandomisedcontrolledtrials AT taguchikazuaki remdesivirforthetreatmentofcoronaviruscovid19ametaanalysisofrandomisedcontrolledtrials AT matsumotokazuaki remdesivirforthetreatmentofcoronaviruscovid19ametaanalysisofrandomisedcontrolledtrials |